Crohn's disease belongs to a group of conditions known as inflammatory bowel diseases (IBD). This chronic condition causes ...

New study shows that dysfunction of protective immune cells in GI tract may contribute to onset of inflammation in Crohn's disease.

A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease ...

A team of scientists has discovered mechanisms of abnormal immune cell function that may lead to Crohn’s disease, an ...

Researchers uncover cellular pathways linked to inflammatory bowel disease onset, offering insights for new therapies to ...

A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease ...

Crohn’s disease can cause digestive issues However since it is an inflammatory disease the symptoms can go beyond the gut ...

More than 150,000 Americans could get diagnosed with colorectal cancer this year, but lifestyle changes can lower your risk, ...

Crohn’s disease is an autoimmune disease and a type of inflammatory bowel disease (IBD). If you have one autoimmune disease, like Crohn’s, you are more likely to have another autoimmune disease.

The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous ...

New Inflammatory Bowel Disease Testing Protocol Could Speed ... sensor to detect inflammatory flareups in patients with Crohn's disease. The approach offers long-term, real-time monitoring ...

With another inflammatory bowel disease (IBD) approval in the bag for Tremfya, Johnson & Johnson continues to make good on ...